Larvol Delta - Anixa-Biosciencesannounced-that-the-Korean-Ministry-of-Intellectual-Property-MOIP-has-issued-Patent-Number-102960889-related-to-Anixa39s-breast-cancer-vaccine-technology

alpha-lactalbumin vaccine - Anixa Biosci, Cleveland Clinic

https://www.prnewswire.com/news-releases/anixa-biosciences-granted-first-korean-patent-for-its-breast-cancer-vaccine-extending-global-protection-through-2040-302812489.html

Jun 29, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next